Table 3.

Characteristics of patients, clinical course, and outcome in CAPA and non-CAPA cases

Parameter	Presumed CAPA (n = 17)	Non-CAPA (n = 102)	pValue
Age, year, median (range)	73.8 (45–88)	61.2 (19–73)	0.024
Sex, M, n (%)	12/17 (70.6)	65/102 (63.7)	0.145
Interval from symptom onset to ICU admission, median (range), d	6 (3–12)	8 (4–16)	0.260
Interval from ICU admission to ICU discharge, median (range), d	10.5 (5–42)	11.2 (3–40)	0.425
Interval from symptom onset to death, median (range), d	16.3 (7–30)	17.7 (10–39)	0.371
Systemic corticosteroid use, n (%)	6/17 (35.3)	14/102 (13.7)	0.031
Mortality, n (%)	13/17 (76.5)	52/102 (50.1)	0.018

CAPA COVID-19-associated pulmonary aspergillosis, COVID-19 coronavirus disease